Market Research Report
China Pharmaceuticals & Healthcare Q4 2019
|Published by||Fitch Solutions, Inc.||Product code||209173|
|Published||Content info||97 Pages
Delivery time: 1-2 business days
|China Pharmaceuticals & Healthcare Q4 2019|
|Published: August 6, 2019||Content info: 97 Pages||
China will continue to benefit from significant investment from the innovative pharmaceutical industry. While the Chinese pharmaceutical market continues to face uncertainty on the back of challenges around drug pricing and the low levels of intellectual property protection, we maintain our view that it presents one of the most attractive investment destinations in the Asia Pacific region. Underpinning this view, China boasts a number of inherent advantages that makes it well positioned for continued FDI flows into the pharmaceutical sector. These include: a rapidly ageing population, a well-established manufacturing industry for pharmaceuticals and notable government commitment to sector development.